6505--Naproxen Tablets

presolicitation

Closed

Presolicitation Notice Page 1 of Presolicitation Notice Page 1 of 3 Presolicitation Notice *=Required Field Presolicitation Notice Page 4 of 4 DESCRIPTION Presolicitation Notice Presolicitation Notice Page 3 of 3 Page 1 of 2 Page 1 of 2 Presolicitation Notice *=Required Field Presolicitation Notice Page 1 of 3 Page 1 of Page 1 of PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0011 for an unrestrictive procurement for Naproxen Tablets for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package unit of use is bottles. Solicitation #36E79726R0011 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 10, 2026, with a tentative closing date of February 24, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: Michael.Olszewski@va.gov. The estimated annual requirements are as follows: ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 NAPROXEN 250MG TAB 100 4,420 2 NAPROXEN 250MG TAB 500 14,256 3 NAPROXEN 375MG TAB 100 1,476 4 NAPROXEN 375MG TAB 500 8,553 5 NAPROXEN 500MG TAB 100 8,994 6 NAPROXEN 500MG TAB 500 115,664

SAM.gov

Tender

Residential, Aerospace & Defense, Forest Products and Packaging, Manufacturing (Industrial), Commercial